Tyvaso
Showing 1 - 25 of 27
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)
Available
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- (no location specified)
Oct 5, 2022
Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic
Not yet recruiting
- Progressive Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
- (no location specified)
Jul 5, 2023
Pulmonary Arterial Hypertension Trial in United States (Treprostinil Inhalation Powder)
Active, not recruiting
- Pulmonary Arterial Hypertension
- Treprostinil Inhalation Powder
-
Birmingham, Alabama
- +18 more
Nov 2, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,
Enrolling by invitation
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Inhaled Treprostinil
- Treprostinil Ultrasonic Nebulizer
-
Kissimmee, Florida
- +2 more
Jul 19, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
- (no location specified)
Feb 15, 2022
Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease Trial in Gainesville (Inhaled Treprostinil)
Recruiting
- Sarcoidosis
- +2 more
- Inhaled Treprostinil
-
Gainesville, FloridaUniversity of Florida, Division of Pulmonary and Critical Care M
Nov 12, 2021
Congenital Heart Disease Trial in Cincinnati (Treprostinil, Placebo)
Terminated
- Congenital Heart Disease
- Treprostinil
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 13, 2020
Pulmonary Arterial Hypertension Trial in Phoenix (L606 inhalation suspension)
Recruiting
- Pulmonary Arterial Hypertension
- L606 inhalation suspension
-
Phoenix, ArizonaArizona Pulmonary Specialists
Jan 26, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil
Recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 16, 2022
Pulmonary Arterial Hypertension Trial in Israel, United States (Beraprost Sodium 314d Modified Release Tablets, Placebo)
Completed
- Pulmonary Arterial Hypertension
- Beraprost Sodium 314d Modified Release Tablets
- Placebo
-
Birmingham, Alabama
- +74 more
Jul 20, 2020
Respiratory Distress Syndrome, Adult Trial in Chapel Hill (Treprostinil Inhalation Solution, Placebo)
Terminated
- Respiratory Distress Syndrome, Adult
- Treprostinil Inhalation Solution
- Placebo
-
Chapel Hill, North CarolinaUniversity of North Carolina Hospitals
Sep 12, 2019
Pulmonary Vascular Disease Trial in Durham (Hyperpolarized 129Xenon gas)
Recruiting
- Pulmonary Vascular Disease
- Hyperpolarized 129Xenon gas
-
Durham, North CarolinaDuke University Medical Center
Oct 3, 2022
Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension Trial in Durham (Hyperpolarized 129Xe)
Not yet recruiting
- Interstitial Lung Disease
- +2 more
- Hyperpolarized 129Xe
-
Durham, North CarolinaDuke University Medical Center
Jan 14, 2022
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Pulmonary Hypertension, COPD Trial in Worldwide (Inhaled treprostinil solution, Placebo solution)
Terminated
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled treprostinil solution
- Placebo solution
-
Birmingham, Alabama
- +75 more
Jan 5, 2023
Pulmonary Arterial Hypertension Trial in Tucson, San Francisco, Torrance (Treprostinil)
Completed
- Pulmonary Arterial Hypertension
-
Tucson, Arizona
- +2 more
Aug 31, 2017
Pulmonary Arterial Hypertension Trial in United States (UT-15C SR, Tyvaso Inhalation Solution)
Completed
- Pulmonary Arterial Hypertension
- UT-15C SR
- Tyvaso Inhalation Solution
-
Birmingham, Alabama
- +5 more
Jan 11, 2017
Hypertension, Pulmonary Trial in Stanford, Chicago (treprostinil inhalations, tadalafil)
Completed
- Hypertension, Pulmonary
- treprostinil inhalations
- tadalafil
-
Stanford, California
- +1 more
Apr 27, 2017
Pulmonary Hypertension, COPD Trial (Inhaled Treprostinil)
Withdrawn
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled Treprostinil
- (no location specified)
Apr 7, 2017
Pulmonary Hypertension, COPD Trial in Aurora, Jacksonville (Inhaled Treprostinil Therapy)
Completed
- Pulmonary Hypertension
- COPD
- Inhaled Treprostinil Therapy
-
Aurora, Colorado
- +1 more
Jul 18, 2016
Respiratory Tract AEs in Patients Treated With Tyvaso® Compared
Completed
- Pulmonary Arterial Hypertension
- inhaled prostacyclin
- +4 more
-
Birmingham, Alabama
- +87 more
Jan 20, 2016
Pulmonary Arterial Hypertension Trial in Puerto Rico, United States
Completed
- Pulmonary Arterial Hypertension
-
La Jolla, California
- +51 more
Mar 20, 2015
Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
Terminated
- Pulmonary Arterial Hypertension
- Chronic Obstructive Pulmonary Disease
-
Jacksonville, Florida
- +2 more
May 6, 2015
Pulmonary Hypertension Trial in Worldwide (Inhaled treprostinil, Placebo inhalation solution)
Completed
- Pulmonary Hypertension
- Inhaled treprostinil
- Placebo inhalation solution
-
Birmingham, Alabama
- +29 more
Jul 11, 2013